查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1649514

管腔貼合金屬支架市場預測（2025-2030）

Lumen Apposing Metal Stent Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 148 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計 2025 年管腔對置金屬支架市場價值將達到 36.78 億美元，到 2030 年預計將達到 47.2 億美元，複合年成長率為 5.12%。

管腔貼合金屬支架 (LAMS) 是專為擴大內視鏡介入範圍而設計的設備。 LAMS 具有啞鈴形狀和短鞍長的特點，專為胰液儲存(PFC) 引流和各種胃腸道疾病的治療而設計。這些支架比傳統支架具有明顯的優勢，特別是在引流效率方面，使其在管壁壞死等情況下特別有用。此外，LAMS 降低了移位的風險並最大限度地減少了侵入性手術的需要。預計全球管腔對置金屬支架市場將在預測期內顯著成長，這主要是由於全球發炎性腸道疾病)盛行率不斷上升。 LAMS 透過提供有效的監測和治療方案，在 IBD 尤其是克隆氏症的管理中發揮重要作用。胃腸道疾病盛行率的上升預計也將促進市場的成長。然而，由於這些程序可能產生的副作用和高成本，管腔對置金屬支架市場的擴張可能會面臨挑戰。總體而言，LAMS 手術比傳統支架置入術更昂貴，多項臨床研究表明，LAMS 手術和傳統支架置入術的結果差異不大。

Lumen 金屬支架市場促進因素

  • 全球 IBD 病例增加：發炎性腸道疾病的不斷上升預計將在預測期內顯著推動管腔對置金屬支架市場的成長。 IBD 是一種影響腸道的慢性疾病，其中克隆氏症和潰瘍性大腸炎是最常見的類型。

在治療 IBD 時，管腔內金屬支架是治療成人胃腸道狹窄的有效工具。近年來，全球克隆氏症症患者數量大幅增加。根據國家生物技術資訊中心的數據，截至 2023 年，加拿大每 10 萬人中報告約 825 例發炎性腸道疾病，預計未來十年的成長率為 2.44%。同樣，根據《胃腸病學顧問》的報告，美國IBD 的盛行率也顯著增加。 2023年美國IBD患者數預計為239萬，其中克隆氏症101萬，潰瘍性大腸炎患者125萬。發生率約為每十萬人721人。

地理視角

  • 北美預計將佔據主導地位：預測期內，北美地區預計將見證管腔金屬支架市場的顯著成長。該地區被公認為生物技術和醫療保健領域規模最大、技術最先進的地區之一。該地區擁有多家領先的醫療技術開發商，尤其是在美國和加拿大。

此外，政府旨在加強醫療保健技術發展的舉措預計將在此期間進一步推動市場成長。北美發炎性腸道疾病和胃腸道疾病的盛行率不斷上升，預計也將推動市場擴張。研究顯示，該地區的IBD和胃腸道疾病病例比其他地區多，主要原因是高度加工食品消費增加，膳食纖維攝取減少。

為什麼要購買這份報告？

  • 深刻分析：獲得深入的市場洞察，涵蓋主要和新興地區，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、垂直行業和其他子區隔。
  • 競爭格局：了解全球主要企業所採用的策略策略，並了解正確策略帶來的潛在市場滲透率。
  • 市場趨勢和促進因素：探索動態因素和關鍵市場趨勢以及它們將如何影響未來的市場發展。
  • 可行的建議：利用洞察力做出策略決策，在動態環境中開闢新的業務流和收益。
  • 受眾廣泛：對於新興企業、研究機構、顧問公司、中小企業和大型企業都有益且具有成本效益。

它有什麼用途？

產業與市場分析、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本支出決策、法律規範與影響、新產品開發、競爭影響

研究範圍

  • 2022 年至 2030 年的實際資料和預測
  • 成長機會、挑戰、供應鏈前景、法規結構、顧客行為、趨勢分析
  • 競爭定位、策略與市場佔有率分析
  • 細分和區域分析，包括收益成長和預測國家
  • 公司概況（策略、產品、財務、主要發展等）

Lumen Aposposing 金屬支架市場區隔與分析如下：

依技術分類

  • 常規 LAMS
  • 電燒輔助 LAMS (EC-LAMS)

按應用

  • 良性膽道狹窄
  • 雙側胰漏
  • 胰臟癌
  • 其他

按最終用戶

  • 醫院
  • 專科門診
  • 門診手術中心
  • 其他

按地區

  • 北美洲
  • 美國
  • 加拿大
  • 墨西哥
  • 南美洲
  • 巴西
  • 阿根廷
  • 其他
  • 歐洲
  • 德國
  • 法國
  • 英國
  • 西班牙
  • 其他
  • 中東和非洲
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 其他
  • 亞太地區
  • 日本
  • 中國
  • 印度
  • 韓國
  • 印尼
  • 泰國
  • 台灣
  • 其他

目錄

第 1 章 簡介

  • 市場概況
  • 市場定義
  • 研究範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要利益

第2章調查方法

  • 研究設計
  • 研究過程

第3章執行摘要

  • 主要發現

第4章 市場動態

  • 市場促進因素
  • 市場限制
  • 波特五力分析
  • 產業價值鏈分析
  • 分析師觀點

5. 管腔內金屬支架市場（依技術分類）

  • 介紹
  • 常規 LAMS
  • 電燒輔助 LAMS (EC-LAMS)

6. 管腔內金屬支架市場（依應用）

  • 介紹
  • 良性膽道狹窄
  • 膽胰漏
  • 胰臟癌
  • 其他

7. 管腔貼合金屬支架市場（依最終用戶分類）

  • 介紹
  • 醫院
  • 專科門診
  • 門診手術中心
  • 其他

8. 管腔內金屬支架市場（按地區）

  • 介紹
  • 北美洲
    • 依技術分類
    • 按應用
    • 按最終用戶
    • 按國家
  • 南美洲
    • 依技術分類
    • 按應用
    • 按最終用戶
    • 按國家
  • 歐洲
    • 依技術分類
    • 按應用
    • 按最終用戶
    • 按國家
  • 中東和非洲
    • 依技術分類
    • 按應用
    • 按最終用戶
    • 按國家
  • 亞太地區
    • 依技術分類
    • 按應用
    • 按最終用戶
    • 按國家

第9章競爭格局及分析

  • 主要企業和策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作
  • 競爭儀錶板

第10章 公司簡介

  • Boston Scientific Corporation
  • Mitra Industries
  • ITPL Medical
  • Olympus America
  • Duomed
簡介目錄
Product Code: KSI061617278

The lumen apposing metal stent market is estimated at US$3.678 billion in 2025, and is expected to grow at a CAGR of 5.12%, attaining US$4.720 billion by 2030.

A lumen-apposing metal stent (LAMS) is a specialized device designed to enhance the scope of endoscopic interventions. Characterized by a dumbbell configuration and short saddle length, LAMS are specifically engineered to drain pancreatic fluid collections (PFCs) and address various gastrointestinal diseases. These stents offer significant advantages over traditional stents, particularly in terms of drainage efficiency, making them especially useful for conditions like walled-off necrosis. Additionally, LAMS have a reduced risk of migration and minimize the need for invasive procedures.The global market for lumen-apposing metal stents is expected to see substantial growth during the forecast period, primarily driven by the increasing incidence of inflammatory bowel diseases (IBD) worldwide. LAMS play a crucial role in managing IBD, particularly in cases of Crohn's disease, by providing effective monitoring and treatment options. The rising prevalence of gastrointestinal disorders is also anticipated to contribute to market growth.However, the expansion of the lumen-apposing metal stent market may face challenges due to the potential for side effects and the higher costs associated with these procedures. Generally, LAMS procedures are more expensive than traditional stent placements, and various clinical studies have shown minimal differences in outcomes between LAMS and conventional stents.

Drivers of the Lumen-Apposing Metal Stent Market

  • Increasing Global Cases of IBD: The rising incidence of inflammatory bowel disease (IBD) is expected to significantly drive the growth of the lumen-apposing metal stent market during the forecast period. IBD is a chronic condition affecting the intestinal tract, with Crohn's disease and ulcerative colitis being among the most common types.

In managing IBD, lumen-apposing metal stents serve as an effective tool for addressing luminal gastrointestinal strictures in adults. Recent years have seen a notable increase in global cases of Crohn's disease. According to the National Center for Biotechnology Information, as of 2023, Canada reported approximately 825 cases of inflammatory bowel diseases per 100,000 individuals, with projections indicating a growth rate of 2.44% over the next decade. The total number of IBD cases in Canada is estimated to be around 320,000.Similarly, a report from Gastroenterology Advisor indicated that the prevalence of IBD in the USA has also risen significantly. In 2023, there were an estimated 2.39 million cases of IBD in the USA, including about 1.01 million cases of Crohn's disease and 1.25 million cases of ulcerative colitis. The prevalence rate was recorded at approximately 721 per 100,000 individuals in the USA.

Geographical Outlook

  • North America Expected to Dominate: The North American region is poised for substantial growth in the lumen-apposing metal stent market during the forecast period. This region is recognized as one of the largest and most technologically advanced areas within biotechnology and healthcare. It hosts several leading technological developers in healthcare, particularly in the United States and Canada.

Additionally, government initiatives aimed at enhancing technological development in healthcare are expected to further boost market growth during this time frame. The increasing prevalence of inflammatory bowel disorders and gastrointestinal diseases in North America is also anticipated to drive market expansion. Research indicates that cases of IBD and gastrointestinal diseases are higher in this region compared to others, largely due to increased consumption of highly processed foods and lower fiber intake.

Reasons for buying this report:-

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data & forecasts from 2022 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The Lumen Apposing Metal Stent Market is segmented and analyzed as:

By Technology

  • Traditional LAMS
  • Electro-cautery LAMS (EC-LAMS)

By Application

  • Benign Biliary Strictures
  • Bilo-Pancreatic Leakages
  • Pancreatic Cancer
  • Others

By End-User

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific Region
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Thailand
  • Taiwan
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key benefits for the stakeholders

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Process

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. The Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. LUMEN APPOSING METAL STENT MARKET BY TECHNOLOGY

  • 5.1. Introduction
  • 5.2. Traditional LAMS
  • 5.3. Electro-cautery LAMS (EC-LAMS)

6. LUMEN APPOSING METAL STENT MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Benign Biliary Strictures
  • 6.3. Bilo-Pancreatic Leakages
  • 6.4. Pancreatic Cancer
  • 6.5. Others

7. LUMEN APPOSING METAL STENT MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Specialty Clinics
  • 7.4. Ambulatory Surgical Centers
  • 7.5. Others

8. LUMEN APPOSING METAL STENT MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Technology
    • 8.2.2. By Application
    • 8.2.3. By End-User
    • 8.2.4. By Country
      • 8.2.4.1. United States
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Technology
    • 8.3.2. By Application
    • 8.3.3. By End-User
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Technology
    • 8.4.2. By Application
    • 8.4.3. By End-User
    • 8.4.4. By Country
      • 8.4.4.1. Germany
      • 8.4.4.2. France
      • 8.4.4.3. United Kingdom
      • 8.4.4.4. Spain
      • 8.4.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Technology
    • 8.5.2. By Application
    • 8.5.3. By End-User
    • 8.5.4. By Country
      • 8.5.4.1. UAE
      • 8.5.4.2. Saudi Arabia
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Technology
    • 8.6.2. By Application
    • 8.6.3. By End-User
    • 8.6.4. By Country
      • 8.6.4.1. Japan
      • 8.6.4.2. China
      • 8.6.4.3. India
      • 8.6.4.4. South Korea
      • 8.6.4.5. Indonesia
      • 8.6.4.6. Thailand
      • 8.6.4.7. Taiwan
      • 8.6.4.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Boston Scientific Corporation
  • 10.2. Mitra Industries
  • 10.3. ITPL Medical
  • 10.4. Olympus America
  • 10.5. Duomed